Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?

[1]  闵先军,et al.  Oesophageal cancer , 2011 .

[2]  J. V. van Sandick,et al.  Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer , 2010, The British journal of surgery.

[3]  E. Steyerberg,et al.  Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. , 2010 .

[4]  R. Malthaner,et al.  Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  J. Hainsworth,et al.  Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Posner,et al.  Neoadjuvant strategies for the treatment of locally advanced esophageal cancer , 2010, Journal of surgical oncology.

[7]  N. Rizk,et al.  Randomized clinical trials in esophageal carcinoma. , 2010, Surgical oncology clinics of North America.

[8]  P. Schlag,et al.  Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: Randomized EORTC phase III trial #40954. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Hong Zhu,et al.  Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. , 2009, World journal of gastroenterology.

[10]  W. Allum,et al.  Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Belka,et al.  Evidence-based radiation oncology: oesophagus. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  T. Crosby,et al.  The management of locally advanced carcinoma of the oesophagus - SCOPE for improvement? , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[13]  M. Stuschke,et al.  Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Steyerberg,et al.  Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS) , 2008, BMC surgery.

[15]  S. Force,et al.  Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. , 2008, The Annals of thoracic surgery.

[16]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  G. Nieuwenhuijzen,et al.  A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer , 2007, Annals of Surgical Oncology.

[18]  L. Kleinberg,et al.  Chemoradiation in the management of esophageal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Ajani,et al.  Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. Wagenius,et al.  A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer , 2007 .

[21]  J. Pignon,et al.  Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial , 2007 .

[22]  B. Manns,et al.  Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. , 2007, The Annals of thoracic surgery.

[23]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Val Gebski,et al.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.

[25]  V. Rusch,et al.  American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  N. Boku.  Randomized Phase III study of 5-fluorouracil alone versus combination of irinotecan and cisplatin versus S-1 alone in advanced gastric cancer (JCOG9912) , 2007 .

[27]  J. Siewert,et al.  Are squamous and adenocarcinomas of the esophagus the same disease? , 2007, Seminars in radiation oncology.

[28]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[29]  S. DeMeester.  Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment , 2006, Annals of Surgical Oncology.

[30]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[31]  Hao Wang,et al.  Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  R. Malthaner,et al.  Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis , 2004, BMC medicine.

[34]  A. Venturi,et al.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.

[35]  J. Lee,et al.  A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  J. Urschel,et al.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. , 2002, American journal of surgery.

[37]  A. Livingstone,et al.  Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials , 2003, Annals of Surgical Oncology.

[38]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[39]  N. Altorki,et al.  Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus , 2002, Annals of surgery.

[40]  D. Girling.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.

[41]  V. Chiarion Sileni,et al.  Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma , 2001, Cancer.

[42]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  M. Iannettoni,et al.  Transhiatal esophagectomy: clinical experience and refinements. , 1999, Annals of surgery.

[44]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[45]  K. Chu,et al.  Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. , 1997, The Journal of thoracic and cardiovascular surgery.

[46]  J. Bosset,et al.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.

[47]  L. Karnell,et al.  National Cancer Data Base report on esophageal carcinoma , 1996, Cancer.

[48]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[49]  P. Puttisak,et al.  A prospective study of combined therapy in esophageal cancer. , 1994, Hepato-gastroenterology.

[50]  A. Geater,et al.  Induction chemotherapy in the treatment of patients with carcinoma of the esophagus , 1994, Journal of surgical oncology.